Drug Type Small molecule drug |
Synonyms 4-desacetylpaclitaxel 4-methyl carbonate, BMS 188797 |
Target |
Action inhibitors |
Mechanism Tubulin inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC47H51NO15 |
InChIKeyGMJWGJSDPOAZTP-MIDYMNAOSA-N |
CAS Registry172481-83-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | - | 26 Jul 2004 | |
Advanced cancer | Phase 1 | United States | 01 Jun 2000 | |
Solid tumor | Phase 1 | United States | 01 Jun 2000 | |
Neoplasms | Phase 1 | United States | - |
Phase 1 | 30 | ezujbuacfx(dzqagnpnyf) = bqqkdffavm hvdfsqtuzp (qfuyuewmhz ) | - | 15 Jan 2006 |